Schedule 13G ownership disclosure

Palisade Bio, Inc.

Common Stock, par value $0.01 per share · CUSIP: 696389402

Event date: 2025-10-06

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Point72 Asset Management, L.P.

    Shares: 7,585,611.00 · Class: 6.2%

  • Point72 Capital Advisors, Inc.

    Shares: 7,585,611.00 · Class: 6.2%

  • Steven A. Cohen

    Shares: 7,585,611.00 · Class: 6.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-004313
Form type
SCHEDULE 13G
Filer
PALISADE BIO, INC.
CIK
CIK 1357459
Filed
Oct 07, 2025
Reporting period
Oct 06, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub